Yan‐Shen Shan

7.5k total citations · 1 hit paper
216 papers, 4.2k citations indexed

About

Yan‐Shen Shan is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Yan‐Shen Shan has authored 216 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Oncology, 81 papers in Surgery and 57 papers in Molecular Biology. Recurrent topics in Yan‐Shen Shan's work include Pancreatic and Hepatic Oncology Research (78 papers), Neuroendocrine Tumor Research Advances (28 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (27 papers). Yan‐Shen Shan is often cited by papers focused on Pancreatic and Hepatic Oncology Research (78 papers), Neuroendocrine Tumor Research Advances (28 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (27 papers). Yan‐Shen Shan collaborates with scholars based in Taiwan, United States and South Korea. Yan‐Shen Shan's co-authors include Li‐Tzong Chen, Pin‐Wen Lin, Hao‐Chen Wang, Ying‐Jui Chao, Edgar D. Sy, Hui‐Ping Hsu, Ya‐Chin Hou, Chih‐Jung Wang, Pin-Wen Lin and Ya-Chin Hou and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and ACS Nano.

In The Last Decade

Yan‐Shen Shan

211 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of gastric cancer in Asia: resource-stratified guidelines

2013 384 citations Yan‐Shen Shan, Kun‐Huei Yeh et al. profile →

Peers

Countries citing papers authored by Yan‐Shen Shan

Since Specialization

Citations

This map shows the geographic impact of Yan‐Shen Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐Shen Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐Shen Shan more than expected).

Fields of papers citing papers by Yan‐Shen Shan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan‐Shen Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐Shen Shan. The network helps show where Yan‐Shen Shan may publish in the future.

Co-authorship network of co-authors of Yan‐Shen Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Yan‐Shen Shan. A scholar is included among the top collaborators of Yan‐Shen Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan‐Shen Shan. Yan‐Shen Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Highly sensitive fluorescence probe for accurate detection of peroxynitrite in mitochondria and imaging inflammation sites 2025 ·Dyes and Pigments ·(unknown), (unknown), (unknown), Yan‐Shen Shan, Kun‐Peng Wang, Xianyuan Xiang, Ying Fang, Shaojin Chen, Zhi‐Qiang Hu	2
2	Arid1a deficiency sensitises pancreatic cancer to fatty acid synthase inhibition 2025 ·Clinical and Translational Medicine ·Tzu‐Lei Kuo, Ya‐Chin Hou, Yan‐Shen Shan, Li‐Tzong Chen, Wen‐Chun Hung	0
3	Improved survival with adding-on strategy after failure of nanoliposomal irinotecan plus 5-fluorouracil and leucovorin in metastatic pancreatic adenocarcinoma 2025 ·Journal of the Formosan Medical Association ·Shih‐Hung Yang, (unknown), (unknown), Hsiang‐Fong Kao, Li‐Chun Lu, Yan‐Shen Shan, Sung‐Hsin Kuo, Kun‐Huei Yeh	0
4	Application of CAPTURE Assay for Early Diagnosis and Prognosis in Bile and Blood of Cholangiocarcinoma 2025 ·JCO Precision Oncology ·(unknown), (unknown), (unknown), Nai‐Jung Chiang, Yu‐Shan Huang, (unknown), Shang‐Cheng Hung, Yan‐Shen Shan, Gwo‐Bin Lee	1
5	Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment 2024 ·Molecular Cancer Therapeutics ·(unknown), Hao‐Chen Wang, Ya‐Chin Hou, (unknown), Chi‐Chang Shieh, Yan‐Shen Shan	7
6	Transcriptome-wide RNA 5-methylcytosine profiles of human iPSCs and iPSC-derived cardiomyocytes 2024 ·Scientific Data ·(unknown), (unknown), Chen‐Yu Huang, (unknown), Yan‐Shen Shan, Yen-Wen Liu, Po-Hsien Huang	0
7	Comparing survival after proximal gastrectomy vs. total gastrectomy in advanced gastric cancer: A systematic review and meta‑analysis 2024 ·Oncology Letters ·(unknown), Yen‐Ta Huang, (unknown), (unknown), Chih‐Jung Wang, Ying‐Jui Chao, Yan‐Shen Shan	1
8	Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer 2023 ·Cancers ·Yung‐Yeh Su, Nai‐Jung Chiang, Yi‐Hsin Yang, Chia‐Jui Yen, Li‐Yuan Bai, Chang‐Fang Chiu, Shih‐Chang Chuang, Shih‐Hung Yang, Wen‐Chi Chou, Jen‐Shi Chen, Tai‐Jan Chiu, Yen‐Yang Chen, De-Chuan Chan, Cheng‐Ming Peng, (unknown), Chung‐Pin Li, Yan‐Shen Shan, Li‐Tzong Chen	5
9	Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study 2022 ·Clinical Cancer Research ·(unknown), Kien Thiam Tan, Li‐Yuan Bai, Chin‐Fu Hsiao, Chung‐Yu Huang, Yi‐Ping Hung, (unknown), San‐Chi Chen, Yan‐Shen Shan, Yee Chao, Yi‐Hsiang Huang, I‐Cheng Lee, Pei‐Chang Lee, Yung‐Yeh Su, Shu‐Jen Chen, Chun‐Nan Yeh, Li‐Tzong Chen, Ming‐Huang Chen	13
10	Synchronization of Nanoparticle Sensitization and Radiosensitizing Chemotherapy through Cell Cycle Arrest Achieving Ultralow X-ray Dose Delivery to Pancreatic Tumors 2021 ·ACS Nano ·Divinah Manoharan, (unknown), (unknown), Yan‐Shen Shan, (unknown), (unknown), Hwo‐Shuenn Sheu, Wen‐Pin Su, Chen‐Sheng Yeh	26
11	Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials 2021 ·Biomolecules ·Nai‐Jung Chiang, Li‐Tzong Chen, Yan‐Shen Shan, Chun‐Nan Yeh, Ming‐Huang Chen	5
12	Combination Delivery of Alpha-Tocopheryl Succinate and Curcumin Using a GSH-Sensitive Micelle (PAH-SS-PLGA) to Treat Pancreatic Cancer 2020 ·Pharmaceutics ·Tilahun Ayane Debele, (unknown), Shang-Rung Wu, Yan‐Shen Shan, Wen‐Pin Su	15
13	Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination 2019 ·Therapeutics and Clinical Risk Management ·(unknown), Yutaka Yonemura, Mao-Chih Hsieh, (unknown), Szu‐Yuan Wu, Yan‐Shen Shan	5
14	Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats 2019 ·Diabetes Metabolic Syndrome and Obesity ·(unknown), Mao-Chih Hsieh, Szu‐Yuan Wu, Edgar D. Sy, Yan‐Shen Shan	8
15	Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues 2018 ·Marine Drugs ·(unknown), (unknown), Chia‐Lun Chang, (unknown), Alexander T.H. Wu, Yan‐Shen Shan, Szu‐Yuan Wu	46
16	Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells 2017 ·Cancer Immunology Research ·Hao‐Chen Wang, (unknown), (unknown), (unknown), Ya‐Chin Hou, (unknown), Yan‐Shen Shan	71
17	KIT Exon 11 Codons 557–558 Deletion Mutation Promotes Liver Metastasis Through the CXCL12/CXCR4 Axis in Gastrointestinal Stromal Tumors 2016 ·Clinical Cancer Research ·Hao‐Chen Wang, (unknown), Ying‐Jui Chao, Ya-Chin Hou, (unknown), (unknown), Yan‐Shen Shan	22
18	Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis 2016 ·Clinical Cancer Research ·(unknown), (unknown), Yi‐Ting Yen, Hung-Chi Cheng, Yi‐Chieh Chen, (unknown), Yu‐Shiuan Wang, Yan‐Shen Shan, Yau‐Lin Tseng, Wu‐Chou Su, Wu‐Wei Lai, Li‐Wha Wu, Yi‐Ching Wang	44
19	Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells 2016 ·The Journal of Experimental Medicine ·Tze‐Sian Chan, Chung‐Chi Hsu, (unknown), Wen‐Ying Liao, Shenq‐Shyang Huang, (unknown), Chia-Jui Yen, Shu-Ching Hsu, Wei‐Yu Chen, Yan‐Shen Shan, Chi–Rong Li, Michael T. Lee, (unknown), (unknown), Gi‐Shih Lien, Valerie M. Weaver, Kelvin K. Tsai	132
20	A phase I study of combination of intravenous gemcitabine, oxaliplatin, and 5-FU with daily oral thalidomide (GOFT) in metastatic/locally advanced pancreatic carcinoma patients. 2008 ·PubMed ·Yan‐Shen Shan, Pin-Wen Lin	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact